The effect of m-CPP on tics and obsessive-compulsive phenomena in Gilles de la Tourette syndrome

Psychopharmacology

Volumn 144, Issue 2, 1999, Pages 137-143

  Cath, Danielle C ^a,b,c   Gijsman, Harm J ^b,c,d   Schoemaker, Rik C ^d   Van Griensven, Jean M T ^d   Troost, Nancy ^c   Van Kempen, Godfried M J ^b,c   Cohen, Adam F ^d  

^a Psychiatric Hospital Amsterdam   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Endegeest Psychiatric Hospital   (Netherlands)

^d CENTRE FOR HUMAN DRUG RESEARCH   (Netherlands)

Author keywords

Gilles de la Tourette syndrome; Impulsions; Meta chlorophenylpiperazine; Obsessive compulsive disorder; Serotonin

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; SEROTONIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DATA ANALYSIS; DOUBLE BLIND PROCEDURE; FEMALE; GILLES DE LA TOURETTE SYNDROME; HUMAN; HYDROCORTISONE BLOOD LEVEL; IMMUNOASSAY; MALE; MIGRAINE; OBSESSION; ORAL DRUG ADMINISTRATION; PANIC; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; SEROTONINERGIC SYSTEM; TIC;

ADULT; AGED; COMPULSIVE BEHAVIOR; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IMPULSIVE BEHAVIOR; MALE; MIDDLE AGED; OBSESSIVE BEHAVIOR; PIPERAZINES; SEROTONIN AGONISTS; TIC DISORDERS; TOURETTE SYNDROME;

EID: 0033059079     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050986     Document Type: Article

References (64)

1. Altemus M, Pigott T, Kalogeras KT, Demitrack M, Dubbert B, Murphy DL, Gold PW (1992) Abnormalities in the regulation of vasopressin and corticotropin releasing factor secretion in obsessive-compulsive disorder. Arch Gen Psychiatry 49:9-20
2. American Psychiatric Association (1987) Diagnostic and statistical manual of mental disorders, 3rd revision. American Psychiatric Press, Washington, D.C.
3. Anderson GM, Pollak ES, Chatterjee D, Leckman JF, Riddle MA, Cohen DJ (1992) Postmortem analysis of subcortical monoamine and amino acids in Tourette syndrome. In: Chase TN, Friedhoff AJ, Cohen DJ (eds) Tourette syndrome: genetics, neurobiology and treatment, vol 58. Raven Press, New York, pp 123-134
4. Apter A, Pauls DL, Bliech A, Zohar AH, Kron S, Ratzoni G, Dycian A, Kotler M, Weizman A, Gadot N, Cohen DJ (1993) An epidemiological study of Gilles de la Tourette's syndrome in Israel. Arch Gen Psychiatry 50:734-738
5. Black DW, Kelly M, Myers C, Noyes R (1990): Tritiated imipramine binding in obsessive-compulsive volunteers and psychiatrically normal controls. Biol Psychiatry 27:319-327
6. Bornstein RA, Baker GB (1992a) Urinary indoleamines in Tourette syndrome patients with obsessive-compulsive characteristics. Psychiatry Res 41:267-274
7. Bornstein RA, Baker GB (1992b) Urinary amines in adults with Tourette's syndrome. Psychiatry Res 43:277-285
8. Buss AH, Plomin R (1975) A temperament theory of personality development. Wiley, New York
9. Buydens-Branchey L, Branchey M, Fergeson P, Hudson J, McKernin C (1998) The meta-chlorophenylpiperazine challenge test in cocaine addicts: hormonal and psychological responses. Biol Psychiatry 41:1071-1086
10. Cath DC, van de Wetering BJM, Hoogduin CAL, Roos RAC, Rooijmans HGM (1992a) Mental play in GTS and obsessive compulsive disorders. Br J Psychiatry 161:542-545
11. Cath DC, Hoogduin CAL, Van de Wetering BJM, Van Woerkom TCAM, Roos RAC, Rooijmans HGM (1992b) Tourette syndrome and obsessive-compulsive disorder - an analysis of associated phenomena. In: Chase TN, Friedhoff AJ, Cohen DN (eds) Advances in neurology, 2nd edn. Raven Press, New York, pp 33-41
12. Charney DS, Goodman WK, Price LH, Woods SW, Rasmussen SA, Heninger GR (1988) Serotonin function in obsessive-compulsive disorder: a comparison of the effects of tryptophan and m-chlorophenylpiperazine in patients and healthy subjects. Arch Gen Psychiaty 45:177-185
13. Cohen DJ, Shaywitz BA, Young JG, Carbonari CM, Nathanson JA, Lieberman D, Bowers MB, Maas JW (1979) Central biogenic amine metabolism in children with the syndrome of chronic multiple tics of Gilles de la Tourette. J Am Acad Child Psychiatry 18:321-341
14. Cohen DJ, Young JG, Shaywitz BA (1980) Clonidine ameliorates Gilles de la Tourette syndrome. Arch Gen Psychiatry 37:1350-1357
15. Comings DE (1990) Blood serotonin and tryptophan in Tourette syndrome. Am J Med Genet 36:418-430
16. De Groot CM, Bornstein RA, Baker GB (1995) Obsessive Compulsive symptom clusters and urinary amine correlates in Tourette's syndrome. J Nerv Ment Dis 183:224-230
17. Eapen V, Robertson MM, Alsobrook JP, Pauls DL (1997) Obsessive compulsive symptoms in Gilles de la Tourette syndrome and obsessive compulsive disorder: differences by diagnosis and family history. Am J Med Genet 74:432-438
18. Fineberg NA, Roberts A, Montgomery SA, Cowen PJ (1997) Brain 5-HT function in obsessive-compulsive disorder. Prolactin responses to d-fenfluramine. Br J Psychiatry 171:280-282
19. George DT, Benkelfat C, Rawlings RR, Eckhardt MJ, Philips MJ, Nutt DJ, Wynne D, Murphy DL, Linnoila M (1997) Behavioral and neuroendocrine responses to m-chlorophenylpiperazine in subtypes of alcoholics and in healthy comparison subjects. Am J Psychiatry 154:81
20. George MS, Trimble MR, Ring HA, Sallee FR, Robertson MM (1993) Obsessions in obsessive-compulsive disorder with and without Gilles de la Tourette's syndrome. Am J Psychiatry 150:93-97
21. Gijsman HJ, Van Gerven JMA, Tieleman MC, Schoemaker RC, Pieters MSM, Ferrari MD et al. (1998) Pharmacokinetic and pharmacodynamic profile of oral and intravenous meta-chlorophenylpiperazine in healthy volunteers. J Clin Psychopharmacol 18:289-295
22. Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischman RL, Hill CL, Heninger GR, Charney DS (1989a) The Yale-Brown Obsessive Compulsive Scale I. Development, use, and reliability. Arch Gen Psychiatry 46:1006-1011
23. Goodman WK, Price, LH, Rasmussen, SA, Mazure C, Delgado P, Heninger GR, Charney DS (1989b) The Yale-Brown Obsessive Compulsive Scale II. Validity. Arch Gen Psychiatry 46:1012-1016
24. Goodman WK, Price LH (1990) Rating scales for obsessive-compulsive disorders. In: Jenike MA, Baer L, Minichiello WE (eds) Obsessive-compulsive disorders: theory and management, 2nd edn. St Louis, p 154
25. Goodman WK, Mc Dougle CJ, Price LH, Barr LC, Hills OF, Caplik JF, Charney DS, Heninger GR (1995) m-Chlorophenylpiperazine in patients with obsessive-compulsive disorder: absence of symptom exacerbation. Biol Psychiatry 38:138-149
26. Greist JH, Jefferson JW, Kobak KA, Katzelnick DJ, Serlin RC (1995) Efficacy and tolerability of serotonin transport inhibitors in obsessive-compulsive disorder. Arch Gen Psychiatry 52:53-60
27. Guy W (1976) Clinical Global Impression scale. ECDEU-Assessment manual for psychopharmacology. Publication 76-338. USA Department of Health, Education and Welfare, Washington D.C.
28. Hartong EGTM, Goekoop JG (1985) De Montgomery Åsberg beoordelingsschaal voor depressie. Tijdschrift voor Psychiatrie 27:657-666
29. Hollander E, Decaria CM, Nitescu A, Gully R, Suckow RF, Cooper TB Gorman JM, Klein DF, Liebowitz MR (1992) Serotonergic function in obsessive compulsive disorder. Behavioral and neuroendocrine responses to oral m-chlorophenylpiperazine and fenfluramine in patients and healthy volunteers. Arch Gen Psychiatry 49:21-28
30. Hollander E (1993) Obsessive-compulsive spectrum disorders: an overview. Psychiatr Ann 23:355-358
31. Hollander E, Stein DJ, De Caria CM, Cohen L, Saoud JB, Skodol AE, Kellman D, Rosnick L, Oldham J (1994) Serotonergic sensitivity in borderline personality disorder: preliminary findings. Am J Psychiatry 151:277-280
32. Holzer JC, Goodman WK, McDougle CJ, Baer L, Boyarski BK, Leckman JF, Price LH (1994) Obsessive-compulsive disorder with and without a chronic tic disorder. Br J Psychiatry 164:469-473
33. Insel TR, Mueller EA, Alterman I, Linnoila M, Murphy DL (1985) Obsessive-compulsive disorder and serotonin: is there a connection? Biol Psychiatry 20:1174-1188
34. Jimerson DC, Wolfe B, Metzger ED, Levine JM, Cooper TB (1994) Blunted neuroendocrine response to serotonergic challenge in bulimia nervosa. Neuropsychopharmacology 10:79S
35. Kahn RS, Wetzler S, Asnis GM, Kling MA, Suckow RF, Van Praag HM (1990) The effects of m-CPP in normal subjects: a dose-response study. Psychopharmacology 100:339-344
36. Kremer HPH, Goekoop JG, Van Kempen MJ (1990) Clinical use of the determination of serotonin in whole blood. J Clin Psychopharmacol 10:83-87
37. Kurlan R, Como PG, Deeley C, Mc Dermott M, Mc Dermott MP (1993) A pilot controlled study of fluoxetine for obsessive-compulsive symptoms in children with Tourette's syndrome. Clin Neuropharmacol 16:167-172
38. Leckman JF, Anderson GM, Cohen DJ, Ort S, Harcherik DF, Hoder EL et al. (1984) Whole blood serotonin and tryptophan levels in Tourette's disorder: effects of acute and chronic clonidine treatment. Life Sci 35:2497-2503
39. Leckman JF, Riddle MA, Hardin MT (1989) The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity. J Am Acad Child Adolescent Psychiatry 28:566-573
40. Leckman JF, Goodman WK, North WG, Chappell PB, Price LH, Pauls DL (1994) Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. Arch Gen Psychiatry 51:782-792
41. Leckman JF, Goodman WK, Anderson GM, Riddle MA, Chappell PB, McSwiggan-Hardin MT, McDougle CJ, Scahill LD, Ort SJ, Pauls DL, Cohen DJ, Price LH (1995) CSF biogenic amines in obsessive-compulsive disorder, Tourette's syndrome, and healthy controls. Neuropsychopharmacology 12:74-86
42. McDougle CJ, Goodman WK, Leckman JF, Barr LC, Heninger GR, Price LH (1993) The efficacy of fluvoxamine in obsessive-compulsive disorder: effects of comorbid chronic tic disorder. J Clin Psychopharmacol 13:354-357
43. McDougle CJ, Goodman WK, Leckman JF, Lee NC, Heninger GR, Price LH (1994) Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. Arch Gen Psychiatry 51:782-792
44. McNair DM, Lorr M, Droppleman LF 28eds) (1971) Manual for the profile of mood states. Educational and Industrial Testing Service, San Diego, Calif.
45. Miguel EC, Coffey BJ, Baer L, Savage CR, Ranch SL, Jenike MA (1995) Phenomenology of intentional repetitive behaviours in obsessive-compulsive disorder and Tourette's disorder. J Clin Psychiatry 56:246-254
46. Miguel EC, Baer L, Coffey BJ, Rauch SL, Savage CR, O'Sullivan RL, Phillips K, Moretti C, Leckman JL, Jenike MA (1997) Phenomenological differences appearing with repetitive behaviours in obsessive-compulsive disorder and Gilles de la Tourette's disorder. Br J Psychiatry 170:140-145
47. Monteleone P, Catapano F, Di Martino S, Ferraro C, Maj M (1997) Prolactin response to d-fenfluramine in obsessive-compulsive patients, and outcome of fluvoxamine treatment. Br J Psychiatry 170:554-557
48. Montgomery SA, Åsberg M (1979) A new depression scale designed to be sensitive to change. Br J Psychiatry 134:382-389
49. Mueller EA, Sunderland T, Murphy DL (1985) Neuroendocrine effects of m-CPP, a serotonin agonist, in humans. J Clin Endocrinol Metab 61:1179-1184
50. Murphy DL, Mueller EA, Hill JL, Tolliver TJ, Jacobsen FM (1989) Comparative anxiogenic, neuroendocrine, and other physiological effects of m-CPP given intravenously or orally to healthy volunteers. Psychopharmacology 98:275-282
51. Murphy, DL, Aulakh C, Mazzola-Pomietto P, Briggs NC (1996) Neuroendocrine responses to serotonergic agonists as indices of the functional status of central serotonin neurotransmission in humans: a preliminary comparative analysis of neuroendocrine endpoints versus other endpoint measures. Behav Brain Res 73:209
52. Oldham JM, Hollander E, Skodol AE (1996) Impulsivity and compulsivity. American Psychiatric Press, Washington, D.C. London
53. Pauls DL, Alsobrook JP, Goodman W, Rasmussen S, Leckman JF (1995) A family study of obsessive-compulsive disorder. Am J Psychiatry 152:76-84
54. Pigott TA, Zohar J, Hill JL, Bernstein SE, Grover GN, Zohar-Gadouch RC, Murphy DL (1991) Metergoline blocks the behavioral and neuroendocrine effects of orally administered m-CPP in patients with obsessive-compulsive disorder. Biol Psychiatry 29:418
55. Pigott TA, Hill JL, Grady TA, L'Heureux F, Bernstein S, Rubenstein CS, Murphy DL (1993) A comparison of the behavioural effects of oral versus intravenous m-CPP administration in OCD patients and the effect of metergoline prior to IV m-CPP. Biol Psychiatry 33:3-14
56. Pitman RK, Green RC, Jenike MA, Mesulam M (1987) Clinical comparison of Tourette's disorder and OCD. Am J Psychiatry 144:1166-1171
57. Shapiro AK, Shapiro E (1993) Neuroleptic drugs in Tourette's syndrome. In: Kurlan R (ed) Handbook of Tourette's syndrome and related behavioral disorders. Marcel Dekker, New York, pp 347-375
58. Spielberger CD, Gorsuch RL, Lushene RE (1970) STAI manual for the State Trait Anxiety Inventory. Consulting Psychologists Press, Palo Alto, Calif.
59. Stein DJ, Hollander E, DeCaria CM, Simeon D, Cohen L, Aronowitz B (1996) m-Chlorophenylpiperazine challenge in borderline personality disorder: relationship of neuroendocrine response, behavioral response and clinical measures. Biol Psychiatry 40:508-513
60. van Balkom AJLM (1994) Comparative treatment studies in panic disorder with agoraphobia and obsessive compulsive disorder. Thesis, Amsterdam Free University
61. Van der Ploeg HM, Defares PB, Spielberger CD (1979) Zelfbeoordelingsvragenlijst STAI versie DY-1 en DY-2. Swets & Zeitlinger BV, Lisse, The Netherlands
62. Van Kempen GMJ, Van Brussel JL, Pennings EJM (1985) Assay of platelet monoamine oxidase in whole blood. Clin Chim Acta 153:197-202
63. Wald FDM, Mellenbergh GJ (1990) De verkorte versie van de Nederlandse vertaling van de Profile of Mood States (POMS). Nederlands Tijdschrift voor Psychologie 45:86-90
64. Zohar J, Mueller EA, Insel TR, Zohar-Kadouch RC, Murphy DL (1987) Serotonergic responsitivity in obsessive compulsive disorder. Comparison of patients and healthy controls. Arch Gen Psychiatry 44:946-951